NRIX
Nurix Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.95
−38.23%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 6.48x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 20.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- 6.35x
- PEG TTM
- —
- Price / book
- 1.80x
- Price / sales
- 2.48x
- Price / cash flow
- 4.59x
Enterprise value
- Enterprise value
- $759.6M
- EV / sales
- 1.08x
- EV / EBITDA
- 2.35x
- EV / EBIT
- 2.62x
- Market cap
- $1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Aug 1, 2026